Patty Sipes Email & Phone Number

Spokane, WA, US

A strategic consulting firm specializing in driving growth and operational excellence across laboratory, diagnostics, and related technology sectors. With expertise that spans clinical laboratories, laboratory-developed tests (LDTs), molecular diagnostics, and capital equipment sales, my practice is tailored to help organizations across industries optimize.

Chicago, IL, US

• The American Pathology Foundation (APF - www.apfconnect.org) is a non-profit professional society devoted to the business and management of pathology. Founded in 1959, the Foundation focuses on providing quality.
• Strategic Appointment: Personally recommended and recruited by Co-President Karim Sirgi, MD, to join the Board of Directors.
• Governance and Oversight: Serving a three-year term, contributing to the strategic direction and governance of the foundation.
• Industry Expertise: Leveraging extensive experience in pathology and business management to support the foundation’s mission and initiatives.

Coppell, Texas, US

• Private equity owned national anatomic pathology laboratory
• Strategic Leadership: Personally recruited by the CEO to prepare the company for a successful capital event (sale).
• Sales Team Optimization: Conducted a comprehensive assessment of the national sales team, implementing necessary changes, revising territory sizes, and introducing performance metrics and reviews to ensure.
• Talent Acquisition: Hired two top-performing Vice Presidents, including one former colleague from PAML, enhancing leadership within the sales team.
• Marketing Revitalization: Revitalized the MARCOM department to enhance brand awareness, developing a comprehensive branding guide and refreshing 50% of outdated and static collateral.
• Commission Plan Overhaul: Thoroughly restructured the existing commission plan to better align with company goals and incentivize performance.

Spokane Valley, WA, US

• Led an organization with $65M in annual revenue and 420 employees, including 50 pathologists. In my first year, I spearheaded the establishment of a new clinical laboratory, filling the gap left by LabCorp’s.
• Organizational Leadership: Led a $65M annual revenue organization with 420 employees and 50 pathologists.
• Strategic Expansion: Successfully launched a clinical laboratory in the Northwest region within the first year, addressing the gap left by LabCorp’s acquisition of PAML in 2017. Oversaw cost controls, completing the.
• Talent Acquisition and Growth: Recruited high-quality talent to drive organizational growth and profitability, fostering an environment of change, progress, and team retention.
• COVID-19 Response and Recovery: Implemented a new revenue channel through COVID-19 testing, recovering from a 70% business loss post-shutdown. Secured government loans and established testing within six weeks.
• Financial Performance: Achieved the strongest cash position in company history, with an 8% growth rate and robust net operating income.

Spokane, WA, US

• For-profit clinical and esoteric reference laboratory owned by Providence Health & Services (PHS) and Catholic Health Initiatives (CHI). Company was sold to LabCorp in May 2017.
• Sales Team Transformation: Rebranded the company, overhauled infrastructure, and implemented necessary leadership changes, enabling the sales team to surpass their quota for the first time in several years.
• Revenue Generation: Spearheaded business development, joint ventures, mergers, acquisitions, and marketing initiatives, contributing $275M to the company’s $350M annual revenue. Developed a joint venture candidate.
• Team Leadership: Directed a team of five direct reports and over 70 sales and marketing representatives, selling esoteric lab testing to primary care physicians and hospital laboratories.
• Employee Retention: Minimized turnover by fostering a communicative and transparent work environment, launching creative incentives and promotion opportunities, and retaining all team members during a 2½-year period.
• Financial Oversight: Developed and managed a multi-million-dollar budget, maintaining P&L responsibility for seven ventures across multiple states.

Parigi, Ile-de-France, FR

• Privately held company with a global presence, specializing in Molecular Laboratory Testing (LDTs) and Molecular Lab Equipment (capital equipment). The company has approximately 90 employees and generates $20M in.
• Pioneering Leadership: As the first commercial hire, established and led a global sales and marketing team for the newly established clinical lab and Ikoniscope® (an automated microscopy system for FISH).
• Regulatory Insight: Identified and resolved inaccuracies in CPT codes used for reimbursement before the official launch of the proprietary laboratory developed test (LDT), oncoFISH® cervical.
• Innovative Solutions: Created the “Ikonisys solution,” allowing customers to start as clinical lab clients and scale up their testing volumes to eventually utilize our automated microscope.
• Revenue Achievement: Met 2009 revenue targets and achieved 100% growth in 2010 with the successful launch of the first signature test offered by Ikonisys, oncoFISH® cervical.
• Team Management: Managed 15-20 sales and marketing staff, maintaining $15M P&L responsibility for the engineering arm of operations.

Burlington, North Carolina, US

• Publicly held Biotech company with 1.24 billion in revenue sales and more than 28,000 employees. Specialized in lab testing, utilized by Hematology/Oncologists, Pathologists, Gastroenterologists, Dermatologists, and.
• Contract Negotiation: Directed a team of up to five managed care staff, negotiating contracts totaling $400M in revenue across 26 states.
• Revenue Growth: Increased existing revenue by negotiating higher reimbursement rates for all contracts associated with EBU tax IDs.
• Comprehensive Management: Led all phases of managed care contract negotiations from inception to completion for the entire Esoteric business unit, including USLABS, Dianon Systems, and Esoterix.
• Operational Optimization: Enhanced cash collection success by collaborating with billing teams to analyze health plan payment history, claim submissions, and accession counts regularly.
• Database Development: Developed a customized Act! Database to facilitate the tracking of contacts, meeting data, pricing, contract terms, billing specifics, and documentation.

• Business Transition: Transitioned to the Oncology side following LabCorp's acquisition of Esoterix in 2005.
• Team Leadership: Managed up to eight direct reports to maximize revenue from leukemia/lymphoma testing services, virtual image capabilities, and specialized coagulation testing.
• High Performance: Built a new team from the ground up, achieving second place out of six teams by 2006.

US

• Sales Leadership: Led a team of eight sales representatives to achieve sales goals for leukemia/lymphoma, specialized coagulation, endocrinology, infectious disease, and allergy testing services.
• Talent Development: Recruited and managed three team members recognized among the top five sales representatives in the country.
• Outstanding Performance: Won Director of the Year and Region of the Year in 2004 and 2005, producing the highest revenue in the company for 24 consecutive months.
• Rookie Development: Hired two team members who later became Rookies of the Year in 2003 and 2004.
• Revenue Management: Managed a $16M revenue portfolio and secured $2.9M in net revenue growth in 2004.

Capital equipment sales for both blood gas and automated immunoassay analyzers, asset management for capital instrument repairs in major hospital systems, and a pioneering management role at Myriad Genetics, where I contributed to the revolutionary BRCA 1 and BRCA 2 genetic testing. This diverse background laid the foundation for a robust understanding of.